Australia Stock Exchange release from PYC THERAP : SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS
17/05/2021 23:23
Australia Stock Exchange release from PYC THERAP PYC.AX : SECOND DRUG PROGRAM - EFFICACY DATA IN PATIENT CELL MODELS
Recent news on PYC Therapeutics
See all newsAustralia's PYC Therapeutics rises on EU orphan drug status
Brief: PYC Therapeutics Posts HY Revenues From Ordinary Activities A$11.0 Million
Brief: PYC Therapeutics Announces Raising Up To A$653 Million
Brief: PYC Therapeutics Seeks Trading Halt
Brief: PYC Therapeutics Says Rohan Hockings Re-Appointed As Managing Director